1. Home
  2. CTNM vs JOUT Comparison

CTNM vs JOUT Comparison

Compare CTNM & JOUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTNM
  • JOUT
  • Stock Information
  • Founded
  • CTNM 2009
  • JOUT 1970
  • Country
  • CTNM United States
  • JOUT United States
  • Employees
  • CTNM N/A
  • JOUT N/A
  • Industry
  • CTNM
  • JOUT Recreational Games/Products/Toys
  • Sector
  • CTNM
  • JOUT Consumer Discretionary
  • Exchange
  • CTNM Nasdaq
  • JOUT Nasdaq
  • Market Cap
  • CTNM 248.7M
  • JOUT 297.3M
  • IPO Year
  • CTNM 2024
  • JOUT N/A
  • Fundamental
  • Price
  • CTNM $12.36
  • JOUT $40.67
  • Analyst Decision
  • CTNM Strong Buy
  • JOUT
  • Analyst Count
  • CTNM 4
  • JOUT 0
  • Target Price
  • CTNM $22.75
  • JOUT N/A
  • AVG Volume (30 Days)
  • CTNM 278.0K
  • JOUT 47.5K
  • Earning Date
  • CTNM 11-05-2025
  • JOUT 08-01-2025
  • Dividend Yield
  • CTNM N/A
  • JOUT 3.22%
  • EPS Growth
  • CTNM N/A
  • JOUT N/A
  • EPS
  • CTNM N/A
  • JOUT N/A
  • Revenue
  • CTNM N/A
  • JOUT $562,527,000.00
  • Revenue This Year
  • CTNM N/A
  • JOUT N/A
  • Revenue Next Year
  • CTNM N/A
  • JOUT $7.39
  • P/E Ratio
  • CTNM N/A
  • JOUT N/A
  • Revenue Growth
  • CTNM N/A
  • JOUT N/A
  • 52 Week Low
  • CTNM $3.35
  • JOUT $21.33
  • 52 Week High
  • CTNM $20.30
  • JOUT $42.88
  • Technical
  • Relative Strength Index (RSI)
  • CTNM 73.06
  • JOUT 58.03
  • Support Level
  • CTNM $10.30
  • JOUT $39.83
  • Resistance Level
  • CTNM $13.26
  • JOUT $42.48
  • Average True Range (ATR)
  • CTNM 1.04
  • JOUT 1.53
  • MACD
  • CTNM 0.03
  • JOUT -0.29
  • Stochastic Oscillator
  • CTNM 77.13
  • JOUT 60.39

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

About JOUT Johnson Outdoors Inc.

Johnson Outdoors Inc is a manufacturer and marketer of branded seasonal, outdoor recreation products used for fishing from a boat, diving, paddling, hiking and camping. The company has four operating segment: Fishing, Camping, Watercraft Recreation, and Diving. It generates maximum revenue from the Fishing segment which produces and markets products under different brands such as Minn Kota electric motors for quiet trolling or primary propulsion, marine battery chargers and shallow water anchors; Humminbird sonar and GPS equipment for fish finding, navigation and marine cartography; and Cannon downriggers for controlled-depth fishing. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe, Canada, and other regions.

Share on Social Networks: